Press release
U.S. Benign Prostatic Hyperplasia Surgical Treatment Market Projected to Reach USD 1,232.65 Million by 2034, Expanding at a CAGR of 5.6%
Polaris Market Research announces the release of its latest study on the U.S. Benign Prostatic Hyperplasia Surgical Treatment market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape.
According to the findings,The U.S. benign prostatic hyperplasia (BPH) surgical treatment market is projected to reach USD 1,232.65 million by 2034, expanding at a CAGR of 5.6% from 2025. The market was valued at USD 714.48 million in 2024.
What is U.S. Benign Prostatic Hyperplasia Surgical Treatment?
U.S. Benign Prostatic Hyperplasia (BPH) surgical treatment involves procedures aimed at relieving urinary symptoms caused by an enlarged prostate gland. Common techniques include transurethral resection of the prostate (TURP), laser therapy, and other minimally invasive options. These surgeries are typically recommended when medications are ineffective. The goal is to improve urinary flow, reduce bladder pressure, and enhance overall quality of life for men experiencing moderate to severe BPH symptoms.
Download Free Sample PDF Copy of the Report:
https://www.polarismarketresearch.com/industry-analysis/us-benign-prostatic-hyperplasia-surgical-treatment-market/request-for-sample
What Is the Report Scope?
Provides a comprehensive analysis of the market, including historical data, current trends, and future projections.
Covers both qualitative and quantitative insights to support strategic decision-making.
Examines key market segments and sub-segments to offer an in-depth market assessment.
Includes detailed regional analysis covering major geographic markets.
Assesses the competitive landscape with profiles of leading players, recent developments, and strategic initiatives.
U.S. Benign Prostatic Hyperplasia Surgical Treatment Market Report Highlights:
Growing Aging Population: The rising number of elderly men in the U.S. is leading to a higher prevalence of BPH, increasing the demand for surgical treatments.
Shift to Minimally Invasive Procedures: Patients and providers are preferring laser and minimally invasive surgeries due to quicker recovery and fewer complications.
Technological Advancements: Innovation in surgical tools and techniques is improving treatment accuracy and patient outcomes.
Strong Healthcare Support: Favorable reimbursement policies and advanced medical infrastructure are boosting access to BPH surgical procedures.
Request for a Discount on this Report Before Purchase:
https://www.polarismarketresearch.com/industry-analysis/us-benign-prostatic-hyperplasia-surgical-treatment-market/request-for-discount-pricing
Who Are Market Key Players?
This market features dynamic competition where prominent organizations continuously innovate and pursue strategic alliances to expand their market share and influence. Key U.S. Benign Prostatic Hyperplasia Surgical Treatment market participants include:
Boston Scientific Corporation
Cleveland Clinic
Cook Medical
Eli Lilly and Company
Medifocus, Inc.
Medtronic
PROCEPT BioRobotics Corporation
Teleflex Incorporated
The Johns Hopkins Hospital
Viatris Inc.
Explore The Complete Comprehensive Report Here:
https://www.polarismarketresearch.com/industry-analysis/us-benign-prostatic-hyperplasia-surgical-treatment-market
Which Region Leads Market Demand?
The global market exhibits varied growth patterns across regions, with certain areas leading due to strong industrial presence, higher investment levels, and favorable economic conditions.
• North America (U.S., Canada)
• Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia)
• Asia Pacific (Japan, China, India, Malaysia, Indonesia. South Korea)
• Latin America (Brazil, Mexico, Argentina)
• Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)
•Latin America(Mexico,Brazil,Argentina,Rest of Latin America)
How Is Market Segmentation Done?
The market segmentation section provides a clearer understanding of demand patterns and growth opportunities across different segments. The market is segmented based on the following key parameters:
By Type Outlook (Revenue, USD Million, 2020-2034)
Transurethral Resection of the Prostate (TURP)
Prostatic Urethral Lift
Water Vapor Therapy
Laser Therapy
Aquablation Therapy
Transurethral Microwave Thermotherapy (TUMT)
Others
By End User Outlook (Revenue, USD Million, 2020-2034)
Hospitals
Ambulatory Surgery Centers and Clinics
Homecare Settings
More Trending Latest Reports by Polaris Market Research:
Aesthetic Medicine Market
https://www.polarismarketresearch.com/industry-analysis/aesthetic-medicine-market
Airway Management Devices Market
https://www.polarismarketresearch.com/industry-analysis/airway-management-devices-market
Alopecia Market
https://www.polarismarketresearch.com/industry-analysis/alopecia-market
Alzheimer's Therapeutics Market
https://www.polarismarketresearch.com/industry-analysis/alzheimers-therapeutics-market
Ambulatory Care Services Market
https://www.polarismarketresearch.com/industry-analysis/ambulatory-care-services-market
Contact:
Likhil G
8 The Green Ste 19824,
Dover, DE 19901,
United States
Phone: +1-929 297-9727
Email: sales@polarismarketresearch.com
Web: https://www.polarismarketresearch.com
Follow Us: LinkedIn | Twitter
About Polaris Market Research & Consulting, Inc:
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR's clientele spread across different enterprises. We at Polaris are obliged to serve PMR's diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR's customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR's customers
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release U.S. Benign Prostatic Hyperplasia Surgical Treatment Market Projected to Reach USD 1,232.65 Million by 2034, Expanding at a CAGR of 5.6% here
News-ID: 4100523 • Views: …
More Releases from Polaris Market Research & Consulting
Cultured Marble Market Projected to Reach USD 7.04 Billion by 2034, Expanding at …
Cultured Marble Market:
Polaris Market Research announces the release of its latest study on the Cultured Marble market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape.
According to the findings,The cultured marble market is projected to reach USD 7.04 billion by 2034, expanding at…
Acrylic and Polycarbonate Sheets Market Projected to Reach USD 19.16 Billion by …
Polaris Market Research has released new insights into the Acrylic and Polycarbonate Sheets market, highlighting key developments, evolving trends, and growth prospects across major regions and segments. The report delivers an in-depth analysis of market dynamics, competitive shifts, and strategic outlooks to support informed decision-making for businesses and investors.
Market at a Glance
Global Acrylic and Polycarbonate Sheets Market size and share is currently valued at USD 10.71 billion in 2024 and…
Undercarriage Components Market Expected to Reach USD 66.13 Billion by 2034, Exp …
Polaris Market Research has released new insights into the Undercarriage Components market, highlighting key developments, evolving trends, and growth prospects across major regions and segments. The report delivers an in-depth analysis of market dynamics, competitive shifts, and strategic outlooks to support informed decision-making for businesses and investors.
Market at a Glance
Global Undercarriage Components Market size and share is currently valued at USD 40.94 billion in 2024 and is anticipated to generate…
Racquet Sports Court Rental Market Projected to Reach USD 12.58 Billion by 2034, …
Polaris Market Research has released new insights into the Racquet sports court rental market, highlighting key developments, evolving trends, and growth prospects across major regions and segments. The report delivers an in-depth analysis of market dynamics, competitive shifts, and strategic outlooks to support informed decision-making for businesses and investors.
Market at a Glance
Global Racquet Sports Court Rental Market size and share is currently valued at USD 7.83 billion in 2024 and…
More Releases for Prostatic
Benign Prostatic Hyperplasia Therapeutics Market Clinical Survey Report 2020
The Benign Prostatic Hyperplasia Therapeutics Market report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Click the link…
Benign prostatic hyperplasia: BPH drugs versus Dr Allen’s Device
The Global Treatment Market of Benign prostatic hyperplasia (BPH) was valued at $10,688.72 million in 2017 and is projected to reach $20,096.68 million by 2025 at a CAGR of 8.1% from 2018 to 2025.
Thermobalancing therapy with Dr Allen’s Device was patented by the United States Patent and Trademark Office. Over a decade, thousands of men with BPH used or are using this non-invasive and side-effects free Dr Allen’s Device.…
Market Outlook: Prostatic Stent Industry Analysis and Trends 2019 – 2025
ResearchMoz include new market research report "Global Prostatic Stent Market Insights, Forecast to 2025" to its huge collection of research reports.
Prostate stents are medical devices used to keep open the space surrounding prostatic urethra and bladder neck in order to allow smooth urine flow in case of urine incontinence. These stents are effective in alleviating the bladder outlet obstruction resulted from benign prostatic hyperplasia (common among men aged above 70…
Benign Prostatic Hyperplasia Therapeutics Market Epidemiology Analysis, Therapy, …
The global benign prostatic hyperplasia therapeutics market is expected to witness significant growth, as increased number of effective treatments are available for cancer. Increasing awareness regarding various cancer treatment drugs, technological advancements, and growing demand for safe and effective medications are acting as the major growth drivers for the benign prostatic hyperplasia therapeutics market. Globally, regulatory bodies are adding to the growth of the market with provision of funding, grants…
Benign Prostatic Hyperplasia and Prostatitis Devicebased Treatments Market
ReportsWorldwide has announced the addition of a new report title Benign Prostatic Hyperplasia and Prostatitis Devicebased Treatments Market to its growing collection of premium market research reports.
This analysis includes a discussion of products, competitors, market forecasts, and opportunities in the global market for BPH and prostatitis treatment devices.
Topics Covered Include:
An overview of device-based and pharmacological therapies for BPH and prostatitis.
Global and country/region-specific market forecasts, including forecasts by product segment.
Competitive analyses…
Benign Prostatic Hyperplasia Therapeutics Development Pipeline Overview for H1 2 …
2017 Benign Prostatic Hyperplasia pipeline market report of on global industry analysis and opportunity assessment H1 report provides comprehensive information on the therapeutics under development for Benign Prostatic Hyperplasia (Male Health), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type.
Get Discount on this Research Report at http://www.reportsnreports.com/contacts/discount.aspx?name=1010746
Benign Prostatic Hyperplasia (BPH) is a non-cancerous enlargement of the prostate, a…
